The implementing regulations,
contained in 21 CFR Part 814, specify the contents of a PMA for a
medical device and the criteria FDA will employ in approving,
denying, or withdrawing approval of a PMA and supplements to PMA's.
The regulation's purpose is to establish an efficient and through
procedure for FDA's review of PMA's and supplements to PMA's for
class III (premarket approval) medical devices. The regulations
also ensure the disapproval of PMA's and supplements to PMA's for
devices that have not been show to be safe and effective and that
do not otherwise meet the statutory criteria for approval.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.